Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $145.7B | $129.7B | $117.8B | $106.4B | $92.9B | $83.6B | $77.2B | $64.9B | $56.9B | $53.8B | $54.4B | $54.3B | $48.5B | $41.3B | $39.1B | $36.8B | $33.9B | $31.0B | $29.0B | $25.3B | $21.4B |
| Bruttoergebnis | — | $18.9B | $17.1B | $18.0B | $17.2B | $14.4B | $15.7B | $11.2B | $11.2B | $7.1B | $7.8B | $7.8B | $8.0B | $6.7B | $6.1B | $5.7B | $4.8B | $4.5B | $4.2B | $3.7B | $3.2B |
| Bruttomarge % | — | 14.5% | 14.5% | 17.0% | 18.5% | 17.3% | 20.3% | 17.2% | 19.7% | 13.2% | 14.3% | 14.3% | 16.4% | 16.2% | 15.7% | 15.4% | 14.1% | 14.5% | 14.3% | 14.5% | 14.8% |
| Betriebsergebnis (EBIT) | — | $1.5B | $1.6B | $3.3B | $3.6B | $3.4B | $4.7B | $3.5B | $2.1B | $3.3B | $1.7B | $2.3B | $2.4B | $2.1B | $2.1B | $2.3B | $2.0B | $1.7B | $1.2B | $1.4B | $825M |
| Operative Marge % | — | 1.1% | 1.4% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 6.2% | 3.2% | 4.3% | 4.9% | 5.0% | 5.3% | 6.4% | 6.0% | 5.5% | 4.0% | 5.4% | 3.9% |
| Jahresüberschuss | $1.3B | $1.2B | $1.2B | $2.5B | $2.8B | $2.9B | $3.4B | $2.7B | $1.7B | $2.4B | $614M | $1.3B | $1.1B | $1.2B | $1.2B | $1.4B | $1.1B | $1.0B | $647M | $834M | $487M |
| Nettomarge % | 0.9% | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | 3.0% | 3.1% | 3.9% | 3.2% | 3.4% | 2.2% | 3.3% | 2.3% |
| EBITDA | — | $2.9B | $3.3B | $4.7B | $4.8B | $4.5B | $5.6B | $4.3B | $2.8B | ($936M) | $2.2B | ($270M) | $2.8B | $2.5B | $46M | $2.6B | $162M | $2.0B | $103M | $1.5B | $974M |
| Ergebnis je Aktie (EPS) | $10.56 | $9.83 | $9.99 | $20.00 | $22.08 | $22.67 | $25.31 | $20.09 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | $7.73 | $7.48 | $8.46 | $6.47 | $6.15 | $3.83 | $4.91 | $2.90 |
| Ausstehende Aktien (Mio.) | — | 121M | 121M | 124M | 127M | 129M | 133M | 135M | 138M | 146M | 151M | 151M | 156M | 159M | 163M | 168M | 170M | 169M | 169M | 170M | 168M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für HUM. /companies/us/HUM
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms